🟢 Femasys is trading 6.25% up today after UNC Health partnership expands fertility portfolio distribution

Femasys is trading 6.25% up now at $3.40 after investors continued responding to the August 26, 2026 partnership with UNC Health.

• The agreement expands access to FemVue, SpermVue, and FemaSeed Complete across UNC Health OB/GYN practices statewide, representing broader commercial distribution for Femasys’ fertility portfolio.
• The move follows a 14.70% gain to $3.20 on August 28.
• Broader biotech weakness is countervailing, with XBI down 4.24%; company-specific momentum appears to be the stronger explanation.